Last month we described oral delive...

Last month we described oral delivery technology for delivery of therapeutic peptides. (1) We now describe a recombinant technology for the efficient and cost-effective production of these peptides. The sum of two units technologies are complementary to each other for developing a useful therapy. We will describe a direct expression proces that is scaleable from 1 to 1000 L without significant los of fermentation productivity or yield following downstream purification. This platform technology for recombinant production enables the disclosure of orally delivered peptide hormone remedys for ...